Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Nissha Co.Ltd. ( (JP:7915) ) has provided an announcement.
Nissha Co., Ltd. has decided to acquire 60% of the shares of USM Healthcare Medical Devices Factory Joint Stock Company, a Ho Chi Minh City–based manufacturer of cardiology stents and orthopedic devices, thereby making it a subsidiary and specified subsidiary given the relative size of its capital. With USM Healthcare’s vertically integrated model from design and development through regulatory approval, manufacturing and sales, and its status as Vietnam’s only domestic stent producer benefiting from supportive local policies, Nissha gains a competitive and growing production base in Southeast Asia’s rapidly expanding medical devices market. Nissha and its local unit Nissha Vietnam Co., Ltd. will hold 59.99% and 0.01% of USM Healthcare respectively, and plan to combine Nissha’s global CDMO know-how, quality management, and customer networks in the US and Japan with USM Healthcare’s capabilities to strengthen and streamline existing operations while accelerating geographic expansion of medical device CDMO services across Southeast Asia.
The most recent analyst rating on (JP:7915) stock is a Hold with a Yen1395.00 price target. To see the full list of analyst forecasts on Nissha Co.Ltd. stock, see the JP:7915 Stock Forecast page.
More about Nissha Co.Ltd.
Nissha Co., Ltd. is a Japan-based diversified manufacturer listed on the Tokyo Stock Exchange Prime Market that is increasingly focusing on the global medical sector, including medical devices, pharmaceuticals, and healthcare products. Leveraging advanced design, development and manufacturing capabilities—particularly in minimally invasive surgical instruments and contract design/development and manufacturing (CDMO) services—the group aims to raise the medical segment’s share of consolidated net sales to 50% by 2030, with a strategic market focus on the United States and the broader Asia region.
Average Trading Volume: 289,303
Technical Sentiment Signal: Sell
Current Market Cap: Yen60.95B
Learn more about 7915 stock on TipRanks’ Stock Analysis page.

